Table 2 Details of the patients in the AH group
Patient | Age | Site | Implant | Diseases | Maintenance | Antihypertensive medication |
|---|---|---|---|---|---|---|
(Sex) | (months) | |||||
1 | 61 | 47 | Brånemark Mk III Groovy | None | 25 | Angiotensin II receptor blockers |
(F) | ||||||
2 | 62 | 24, 27, 45, 47 | Brånemark Mk III Groovy | None | 35 | Calcium antagonists |
(F) | ||||||
3 | 57 | 36, 37, 46 | Brånemark Mk III Groovy | Peri-implant mucositis [46] | 52 | Calcium antagonists |
(M) | Peri-implantitis [37] | Angiotensin II receptor blockers | ||||
4 | 63 | 14, 15, 25 | Replace Select Tapered | Peri-implantitis [15, 25] | 116 | Angiotensin II receptor blockers |
(F) | ||||||
5 | 55 | 46, 47 | Replace Select Straight | Peri-implant mucositis [47] | 108 | Angiotensin II receptor blockers |
(M) | ||||||
6 | 77 | 24, 26, 27 | Replace Select Tapered | Peri-implant mucositis [24] | 165 | Calcium antagonists |
(M) | ||||||
7 | 84 | 15, 16, 36, 46 | Replace Groovy Straight | Peri-implantitis [15, 16] | 153 | Angiotensin II receptor blockers |
(M) | ||||||
8 | 67 | 16, 23, 25, 26, 36, 46 | Replace Groovy Straight | Peri-implant mucositis [26] | 132 | Calcium antagonists |
(F) | Peri-implantitis [16, 23, 25, 46] | |||||
9 | 64 | 25, 27 | Replace Groovy Straight | None | 37 | Calcium antagonists |
(M) | ||||||
10 | 68 | 13, 15 | Replace Groovy Straight | None | 15 | Angiotensin II receptor blockers |
(F) | ||||||
11 | 80 | 24 | Replace Select Tapered | Peri-implant mucositis [24] | 164 | Calcium antagonists |
(M) | ||||||
12 | 63 | 15, 16 | Replace Groovy Straight | Peri-implant mucositis [15] | 27 | Angiotensin II receptor blockers |
(M) | Thiazide diuretics | |||||
13 | 51 | 37 | Brånemark Mk III Groovy | None | 28 | Angiotensin II receptor blockers |
(M) |